Agios Pharma (AGIO) Reports In-Line Q2 EPS
Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.41), in-line with the analyst estimate of ($1.41).
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.41), in-line with the analyst estimate of ($1.41).
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.